Alkermes plc is a fully-integrated, global biopharmaceutical company developing innovative medicines in the fields of neuroscience and oncology. The company has a portfolio of proprietary commercial products focused on alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder, and a pipeline of product candidates in development for neurological disorders and cancer. Headquartered in Dublin, Ireland, Alkermes plc has an R&D center in Waltham, Massachusetts; a research and manufacturing facility in Athlone, Ireland; and a manufacturing facility in Wilmington, Ohio. For more information, please visit Alkermes' website at www.alkermes.com.
POSTED
11-29-22
POSTED
11-08-22
POSTED
09-30-22
POSTED
08-17-22
POSTED
07-15-22
POSTED
06-24-22
POSTED
06-15-22
POSTED
06-07-22
POSTED
06-02-22
POSTED
05-20-22